Our study revealed that high methylation status of CD146 was often more frequently in high-grade and late-stage ccRCC, which may suggest that the pattern of methylation changes of CD146 promotes ccRCC progression. This evidence concerns the gene MCAM and nonpapillary renal cell carcinoma.